Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-estradiol positron emission tomography/computed tomography for the assessment of estrogen receptor status of recurrent or metastatic lesions in patients with breast cancer: an open label, non-randomized, phase 3 study

Sun Young Chae, Sei Hyun Ahn, Sung-Bae Kim, Byung Ho Son, Jong Won Lee, Beom Seok Ko, Jin-Hee Ahn, Kyung Hae Jung, Jeong Eun Kim, Woo Jung Choi, Hee Jung Shin, Gyungyub Gong, Suk Hyun Lee, Sang Ju Lee, Seung Jun Oh, SEOG-YOUNG KIM, Jung Bok Lee and Dae Hyuk Moon
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 487;
Sun Young Chae
3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sei Hyun Ahn
7Surgery Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Bae Kim
4Oncology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Byung Ho Son
7Surgery Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jong Won Lee
7Surgery Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beom Seok Ko
7Surgery Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-Hee Ahn
4Oncology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyung Hae Jung
4Oncology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeong Eun Kim
4Oncology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Woo Jung Choi
6Radiology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hee Jung Shin
6Radiology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gyungyub Gong
5Pathology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suk Hyun Lee
3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sang Ju Lee
3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung Jun Oh
3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SEOG-YOUNG KIM
2Convergence Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jung Bok Lee
1Clinical Epidemiology & Biostatistics Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dae Hyuk Moon
3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 59 no. supplement 1 487

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 23, 2018.

Copyright & Usage 
© 2018

Author Information

  1. Sun Young Chae3,
  2. Sei Hyun Ahn7,
  3. Sung-Bae Kim4,
  4. Byung Ho Son7,
  5. Jong Won Lee7,
  6. Beom Seok Ko7,
  7. Jin-Hee Ahn4,
  8. Kyung Hae Jung4,
  9. Jeong Eun Kim4,
  10. Woo Jung Choi6,
  11. Hee Jung Shin6,
  12. Gyungyub Gong5,
  13. Suk Hyun Lee3,
  14. Sang Ju Lee3,
  15. Seung Jun Oh3,
  16. SEOG-YOUNG KIM2,
  17. Jung Bok Lee1 and
  18. Dae Hyuk Moon3
  1. 1Clinical Epidemiology & Biostatistics Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  2. 2Convergence Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  3. 3Nuclear Medicine Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  4. 4Oncology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  5. 5Pathology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  6. 6Radiology Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of
  7. 7Surgery Asan Medical Center, University of Ulsan college of Medicine Seoul Korea, Republic of

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2018 to April 2025

AbstractFullPdf
May 2018300
Jun 20184200
Jul 20184400
Aug 20182000
Sep 20181200
Oct 20181900
Nov 20182200
Dec 20181800
Jan 20191900
Feb 20192100
Mar 20191500
Apr 20191200
May 2019100
Jun 20191000
Jul 2019100
Aug 20191100
Sep 20191300
Oct 20191100
Nov 20191400
Dec 20191200
Jan 20201700
Feb 20201000
Mar 20202100
Apr 20201600
May 2020700
Jun 2020300
Jul 20201200
Aug 20205100
Sep 20203100
Oct 20201800
Nov 20201400
Dec 2020900
Jan 2021400
Feb 20211300
Mar 2021900
Apr 20213200
May 202114300
Jun 20212600
Jul 20218900
Aug 20216400
Sep 20211600
Oct 20212200
Nov 20218200
Dec 20214400
Jan 20226100
Feb 20222000
Mar 20222600
Apr 20221300
May 20222200
Jun 2022200
Jul 2022700
Aug 2022400
Sep 2022200
Oct 2022600
Nov 2022300
Dec 2022300
Jan 2023700
Feb 2023300
Mar 20231100
Apr 2023200
May 2023800
Jun 2023400
Jul 2023300
Aug 2023500
Sep 2023400
Oct 2023500
Nov 20231100
Dec 2023800
Jan 2024800
Feb 2024300
Mar 2024600
Apr 20241500
May 2024800
Jun 2024200
Jul 2024400
Aug 20241400
Sep 2024800
Oct 2024400
Nov 2024800
Dec 2024800
Jan 2025300
Feb 20252000
Mar 2025700
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-estradiol positron emission tomography/computed tomography for the assessment of estrogen receptor status of recurrent or metastatic lesions in patients with breast cancer: an open label, non-randomiz…
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-estradiol positron emission tomography/computed tomography for the assessment of estrogen receptor status of recurrent or metastatic lesions in patients with breast cancer: an open label, non-randomized, phase 3 study
Sun Young Chae, Sei Hyun Ahn, Sung-Bae Kim, Byung Ho Son, Jong Won Lee, Beom Seok Ko, Jin-Hee Ahn, Kyung Hae Jung, Jeong Eun Kim, Woo Jung Choi, Hee Jung Shin, Gyungyub Gong, Suk Hyun Lee, Sang Ju Lee, Seung Jun Oh, SEOG-YOUNG KIM, Jung Bok Lee, Dae Hyuk Moon
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 487;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diagnostic accuracy and safety of 16α-[18F]fluoro-17β-estradiol positron emission tomography/computed tomography for the assessment of estrogen receptor status of recurrent or metastatic lesions in patients with breast cancer: an open label, non-randomized, phase 3 study
Sun Young Chae, Sei Hyun Ahn, Sung-Bae Kim, Byung Ho Son, Jong Won Lee, Beom Seok Ko, Jin-Hee Ahn, Kyung Hae Jung, Jeong Eun Kim, Woo Jung Choi, Hee Jung Shin, Gyungyub Gong, Suk Hyun Lee, Sang Ju Lee, Seung Jun Oh, SEOG-YOUNG KIM, Jung Bok Lee, Dae Hyuk Moon
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 487;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Breast Cancer: Novel Tracers, Response Biomarkers, and Therapy

  • Exploring the theranostic role of Lu-177 herceptin in HER2 expressing breast cancer: Preliminary studies on comparison with F-18-FDG PET/CT
  • FDG-PET/CT versus contrast-enhanced CT for response evaluation in metastatic breast cancer - a systematic review
  • 68Ga-NOTA-RM26 PET/CT in the Evaluation of Breast Cancer: A Pilot Prospective Study
Show more Breast Cancer: Novel Tracers, Response Biomarkers, and Therapy

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire